United States · FDA National Drug Code directory
OSELTAMIVIR PHOSPHATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-904_4e8c50c0-4026-4047-ac0b-6d8bbb56f923
- Product NDC
- 69097-904
- Form
- FOR SUSPENSION
- Composition / generic term
- OSELTAMIVIR PHOSPHATE
- Labeler
- Cipla USA, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230116
- Source listing expiry
- 20261231
Source-listed ingredients
- OSELTAMIVIR PHOSPHATE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (69097-904-43) / 60 mL in 1 BOTTLE · 69097-904-43
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →